FCER2 T2206C variant associated with FENO levels in asthmatic children using inhaled corticosteroids: The PACMAN study.

Authors:
Karimi L; Vijverberg SJH; Farzan N; Ghanbari M; Verhamme KMC and 1 more

Journal:
Clin Exp Allergy

Publication Year: 2019

DOI:
10.1111/cea.13460

PMCID:
PMC6899548

PMID:
31309641

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Clin Exp Allergy

Abbreviation: Clin Exp Allergy

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Allergy and Immunology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Anaphylaxis in Brazil between 2011 and 2019.
Tanno LK; Molinari N; Annesi-Maesano I and 2 more (2022) - Transparency Score: 3/6
Anti-phospholipid antibodies are elevated and functionally active in chronic rhinosinusitis with na…
Eide JG; Wu J; Stevens WW and 16 more (2022) - Transparency Score: 3/6
Association between allergic sensitization and intestinal parasite infection in schoolchildren in G…
Brandt O; Wegenstein B; Müller I and 12 more (2022) - Transparency Score: 3/6
Burden of allergic disease among ethnic minority groups in high-income countries.
Jones CJ; Paudyal P; West RM and 5 more (2022) - Transparency Score: 2/6
Efficacy of N-acetyl aspartyl glutamic acid versus fluorometholone for treating allergic conjunctiv…
de Blay F; Gherasim A; Domis N and 2 more (2022) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST The authors declare no conflict of interest."

Evidence found in paper:

"The PACMAN study was supported by an unrestricted research grant from GSK. Anke H. Maitland‐van der Zee (AHMZ) received unrestricted funding from GSK and Boehringer Ingelheim. AHMZ received honoraria for participating in advisory boards from Astra Zeneca, GSK, and Boehringer Ingelheim. Katia Verhamme works for a research group, who in the past, received unconditional research grants from Pfizer, Boehringer Ingelheim, Yamanouchi and GSK; none of which are related to the content of this paper."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025